Literature DB >> 15514410

A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.

John T O'Brien1, Adrian Lloyd, Ian McKeith, Anil Gholkar, Nicol Ferrier.   

Abstract

OBJECTIVE: This study determined whether cognitive impairments and structural brain changes in older depressed subjects, especially in the hippocampus, are related to hypercortisolemia.
METHOD: Sixty-one depressed subjects over age 60 who met DSM-IV criteria for major depression and 40 healthy comparison subjects underwent structural magnetic resonance imaging, neuropsychological testing, apolipoprotein E (APOE) genotyping, and salivary cortisol assessment (over 3 days) with follow-up 6 months later. Hippocampal volume was measured by manual segmentation that was blind to diagnosis. Average area under the curve for salivary cortisol over the 3 days was calculated. Cognitive function was assessed by using a combined memory z score.
RESULTS: Depressed subjects showed multiple impairments in attention, working memory, visual memory, verbal memory, new learning, and executive function in relation to comparison subjects. They had hypercortisolemia (53% increase in area under the curve) and a reduction in right hippocampal volume (6% decrease). Hippocampal volume reduction was not associated with increased cortisol levels but was significantly correlated with continuing memory deficits at 6 months. Persisting "mild cognitive impairment" was seen in 20 (41%) of 49 subjects at 6 months and was associated with reduced hippocampal volume but not severity of depression, cortisol levels, or APOE genotype.
CONCLUSIONS: Older depressed subjects have persisting cognitive impairments associated with hippocampal volume reduction, but the results do not support cortisol-mediated hippocampal neurotoxicity as the major etiological mechanism. Neuropathological studies are required to investigate the basis for hippocampal changes, while follow-up will determine whether hippocampal atrophy is a risk factor for cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15514410     DOI: 10.1176/appi.ajp.161.11.2081

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  120 in total

1.  Hippocampal atrophy: another common pathogenic mechanism of depressive disorders and epilepsy?

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2011-09       Impact factor: 7.500

2.  Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia.

Authors:  Mirjam I Geerlings; Adam M Brickman; Nicole Schupf; Davangere P Devanand; José A Luchsinger; Richard Mayeux; Scott A Small
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol.

Authors:  Marina Boccardi; Rossana Ganzola; Martina Bocchetta; Michela Pievani; Alberto Redolfi; George Bartzokis; Richard Camicioli; John G Csernansky; Mony J de Leon; Leyla deToledo-Morrell; Ronald J Killiany; Stéphane Lehéricy; Johannes Pantel; Jens C Pruessner; H Soininen; Craig Watson; Simon Duchesne; Clifford R Jack; Giovanni B Frisoni
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 4.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

5.  Disruption of amygdala-entorhinal-hippocampal network in late-life depression.

Authors:  Stephanie L Leal; Jessica A Noche; Elizabeth A Murray; Michael A Yassa
Journal:  Hippocampus       Date:  2017-02-07       Impact factor: 3.899

6.  Positive emotions: exploring the other hemisphere in behavioral medicine.

Authors:  Margaret A Chesney; Lynae A Darbes; Kate Hoerster; Jonelle M Taylor; Donald B Chambers; David E Anderson
Journal:  Int J Behav Med       Date:  2005

7.  Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

8.  Hippocampal morphology and distinguishing late-onset from early-onset elderly depression.

Authors:  Martina Ballmaier; Katherine L Narr; Arthur W Toga; Virginia Elderkin-Thompson; Paul M Thompson; Liberty Hamilton; Ebrahim Haroon; Daniel Pham; Andreas Heinz; Anand Kumar
Journal:  Am J Psychiatry       Date:  2007-11-06       Impact factor: 18.112

Review 9.  Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus.

Authors:  Joshua J Joseph; Sherita H Golden
Journal:  Ann N Y Acad Sci       Date:  2016-10-17       Impact factor: 5.691

10.  Hippocampal changes associated with early-life adversity and vulnerability to depression.

Authors:  Uma Rao; Li-Ann Chen; Anup S Bidesi; Mujeeb U Shad; M Albert Thomas; Constance L Hammen
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.